Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-May-22 5:15 PM View:  | Immuneering Corp (IMRX) | 16-May-22 | Private Purchase | 7,000 | $5.00 | $35,000.00 | 100% 7.0K to 14.0K | |
| 19-Jan-23 5:17 PM View: | Pepgen Inc. (PEPG) | 06-May-22 | Purchase | 4,166 | $12.00 | $49,992.00 | 100% 0 to 4.17K | |
| 09-Aug-21 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Aug-21 | Option Exercise | 10,000 | $88.95 | $889,500.00 | 180% 5.57K to 15.57K | |
| 09-Aug-21 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Aug-21 | Market Option Sale (Planned) | 10,000 | $188.95 | $1,889,500.00 | (64%) 15.57K to 5.57K | |
| 04-Aug-21 6:06 AM View: | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 7,000 | $15.00 | $105,000.00 | 100% 0 to 7.0K | |
| 14-Jul-21 4:58 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jul-21 | Option Exercise | 6,812 | $87.90 | $598,770.00 | 122% 5.57K to 12.38K | |
| 14-Jul-21 4:58 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jul-21 | Market Option Sale (Planned) | 6,812 | $178.96 | $1,219,100.00 | (55%) 12.38K to 5.57K | |
| 11-Jun-21 4:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Jun-21 | Market Sale (Planned) | 1,734 | $154.00 | $267,036.00 | (24%) 7.3K to 5.57K | (6%) |
| 21-Apr-21 6:21 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-21 | Payment of Exercise | 2,089 | $131.85 | $275,426.00 | (22%) 9.39K to 7.3K | |
| 21-Apr-21 6:21 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Apr-21 | Grant | 4,518 | -- | -- | 93% 4.87K to 9.39K | |
| 16-Feb-21 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Feb-21 | Payment of Exercise | 1,963 | $155.87 | $305,967.00 | (29%) 6.83K to 4.87K | |
| 16-Feb-21 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Feb-21 | Grant | 4,166 | -- | -- | 156% 2.67K to 6.83K | |
| 15-Jan-21 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Jan-21 | Option Exercise | 9,027 | $82.45 | $744,290.00 | 338% 2.67K to 11.7K | |
| 15-Jan-21 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Jan-21 | Market Option Sale (Planned) | 9,027 | $169.90 | $1,533,700.00 | (77%) 11.7K to 2.67K | |
| 13-Jan-21 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jan-21 | Option Exercise | 14,941 | $72.83 | $1,088,150.00 | 560% 2.67K to 17.61K | |
| 13-Jan-21 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jan-21 | Market Option Sale (Planned) | 14,183 | $160.21 | $2,272,180.00 | (81%) 17.61K to 3.43K | |
| 13-Jan-21 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jan-21 | Market Sale (Planned) | 758 | $160.21 | $121,435.00 | (22%) 3.43K to 2.67K | |
| 13-Jan-21 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Jan-21 | Market Option Sale (Planned) | 758 | $154.00 | $116,732.00 | (22%) 3.43K to 2.67K | (8%) |
| 14-Jul-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Jul-20 | Option Exercise | 35,750 | $87.16 | $3,116,070.00 | 240% 14.93K to 50.68K | |
| 14-Jul-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Jul-20 | Market Option Sale (Planned) | 35,750 | $160.67 | $5,744,050.00 | (71%) 50.68K to 14.93K | |
| 14-Jul-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Jul-20 | Market Sale (Planned) | 11,500 | $160.67 | $1,847,740.00 | (77%) 14.93K to 3.43K | |
| 22-Apr-20 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-20 | Option Exercise | 10,000 | $77.40 | $774,000.00 | 67% 14.93K to 24.93K | (8%) |
| 22-Apr-20 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-20 | Market Option Sale (Planned) | 10,000 | $139.00 | $1,390,000.00 | (40%) 24.93K to 14.93K | |
| 09-Apr-20 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Grant | 4,167 | -- | -- | 33% 12.69K to 16.86K | |
| 09-Apr-20 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Payment of Exercise | 1,933 | $104.78 | $202,548.00 | (11%) 16.86K to 14.93K | |
| 12-Feb-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-20 | Option Exercise | 10,000 | $77.40 | $774,000.00 | 79% 12.69K to 22.69K | (8%) |
| 12-Feb-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-20 | Market Option Sale (Planned) | 10,000 | $129.00 | $1,290,000.00 | (44%) 22.69K to 12.69K | |
| 31-Jan-20 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Jan-20 | Option Exercise | 6,337 | $77.40 | $490,484.00 | 70% 9.03K to 15.37K | (8%) |
| 31-Jan-20 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Jan-20 | Market Option Sale | 6,337 | $119.00 | $754,103.00 | (41%) 15.37K to 9.03K | |
| 29-Jan-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Jan-20 | Option Exercise | 34,374 | $42.22 | $1,451,270.00 | 219% 15.69K to 50.07K | |
| 29-Jan-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Jan-20 | Market Option Sale (Planned) | 34,374 | $117.70 | $4,045,750.00 | (69%) 50.07K to 15.69K | |
| 29-Jan-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Jan-20 | Market Sale (Planned) | 6,663 | $117.70 | $784,221.00 | (42%) 15.69K to 9.03K | |
| 26-Nov-19 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Oct-19 | Acquisition (other) | 10 | -- | -- | < 1% 15.68K to 15.69K | |
| 07-Aug-19 4:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Jul-19 | Acquisition (other) | 49 | -- | -- | < 1% 15.63K to 15.68K | |
| 07-Jun-19 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Apr-19 | Acquisition (other) | 41 | -- | -- | < 1% 15.59K to 15.63K | |
| 07-Jun-19 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Oct-18 | Acquisition (other) | 14 | -- | -- | < 1% 15.58K to 15.59K | |
| 14-Aug-18 6:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Aug-18 | Grant | 1,363 | -- | -- | 9% 14.82K to 16.18K | |
| 14-Aug-18 6:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Aug-18 | Payment of Exercise | 605 | $90.95 | $55,024.80 | (4%) 16.18K to 15.58K | 8% |
| 14-Aug-18 6:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-18 | Acquisition (other) | 32 | -- | -- | < 1% 14.79K to 14.82K | |
| 22-Jun-18 4:20 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Jun-18 | Option Exercise | 1,563 | $42.22 | $65,989.90 | 11% 14.79K to 16.35K | |
| 22-Jun-18 4:20 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Jun-18 | Market Option Sale (Planned) | 1,563 | $105.04 | $164,178.00 | (10%) 16.35K to 14.79K | 20% |
| 22-Jun-18 4:20 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Apr-18 | Acquisition (other) | 31 | -- | -- | < 1% 14.76K to 14.79K | |
| 22-Mar-18 6:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Mar-18 | Option Exercise | 1,562 | $42.22 | $65,947.60 | 11% 14.76K to 16.32K | |
| 22-Mar-18 6:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Mar-18 | Market Option Sale (Planned) | 1,562 | $149.83 | $234,033.00 | (10%) 16.32K to 14.76K | 44% |
| 14-Mar-18 7:40 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Option Exercise | 10,000 | $77.40 | $774,000.00 | 68% 14.76K to 24.76K | |
| 14-Mar-18 7:40 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Market Option Sale (Planned) | 10,000 | $150.00 | $1,500,000.00 | (40%) 24.76K to 14.76K | 44% |
| 14-Mar-18 7:40 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Mar-18 | Option Exercise | 10,000 | $77.40 | $774,000.00 | 68% 14.76K to 24.76K | |
| 14-Mar-18 7:40 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Mar-18 | Market Option Sale (Planned) | 10,000 | $140.00 | $1,400,000.00 | (40%) 24.76K to 14.76K | 40% |
| 03-Jan-18 5:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Dec-17 | Option Exercise | 3,000 | $77.40 | $232,200.00 | 26% 11.76K to 14.76K | |
| 21-Dec-17 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Dec-17 | Option Exercise | 6,249 | $42.22 | $263,833.00 | 53% 11.76K to 18.01K |